HCC in the Era of Direct-Acting Antiviral Agents (DAAs): Surgical and Other Curative or Palliative Strategies in the Elderly

HCC in the Era of Direct-Acting Antiviral Agents (DAAs): Surgical and Other Curative or Palliative Strategies in the Elderly

Hepatocellular carcinoma (HCC) accounts for 75–85% of primary liver malignancies, and elderlies have the highest incidence rates. Direct-acting antiviral agents (DAAs) have shown satisfying results in terms of HCV sustained viral response (SVR). However, data regarding HCC risk post-DAA-SVR is still...

Full description

Bibliographic Details
Main Authors: Stefania Brozzetti, Marsia Tancredi, Simone Bini, Chiara De Lucia, Jessica Antimi, Chiara D’Alterio, Giuseppe Maria De Sanctis, Caterina Furlan, Vittoria Carolina Malpassuti, Pierleone Lucatelli, Michele Di Martino, Mario Bezzi, Antonio Ciardi, Rosa Maria Pascale
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Cancers
Subjects:
hepatocellular carcinoma
hepatitis C virus
HCV
HCC
HCC recurrence
DAA
Online Access:https://www.mdpi.com/2072-6694/13/12/3025

Internet

https://www.mdpi.com/2072-6694/13/12/3025

Similar Items